Ceruloplasmin and Heart Failure in the Atherosclerosis Risk in Communities (ARIC) Study

BACKGROUND: Ceruloplasmin (Cp) decreases nitric oxide bioavailability in blood and has been associated with cardiovascular disease (CVD) in clinical studies. We assessed the association between Cp and incident heart failure (HF), death and CVD in the Atherosclerosis Risk in Communities (ARIC) Study....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dadu, Razvan T., Dodge, Rhiannon, Nambi, Vijay, Virani, Salim S., Hoogeveen, Ron C., Smith, Nicholas L., Chen, Fengju, Pankow, James S., Guild, Cameron, Tang, W. H. Wilson, Boerwinkle, Eric, Hazen, Stanley L., Ballantyne, Christie M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908901/
https://ncbi.nlm.nih.gov/pubmed/23861484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.113.000270
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares